ArticleMedicine2026
Mediating roles of systemic immune-inflammation index and body mass index in the association between dietary inflammatory index and cardiovascular disease in diabetes.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study aimed to analyze the dietary inflammatory index (DII) and its impact on cardiovascular disease (CVD) in individuals with diabetes and to explore the role of the systemic immune-inflammation index (SII) and body mass index (BMI) in the relationship between DII and CVD. Data were obtained from the National Health and Nutrition Examination Survey 2009 to 2023. A generalized linear model was used to examine the influence of DII on CVD among individuals with diabetes. The mediation effect model was employed to examine the relationship between DII, SII, BMI, and CVD among individuals with diabetes. Among 5068 participants, 1243 (24.53%) had diabetes mellitus (DM) with CVD. DII was a risk factor for CVD among individuals with diabetes (odds ratio = 1.140, 95% confidence interval [CI]: 1.091-1.192, P < .001). BMI partially mediated the relationship between DII and CVD among adults with DM, with an effect coefficient of 0.005 (95% CI: 0.001-0.010). SII partially mediated the relationship between DII and CVD among adults with DM, with an effect coefficient of 0.008 (95% CI: 0.001-0.016). Among adults with DM, we should pay attention to monitoring the level of DII and reducing BMI, which may help reduce the risk of comorbid CVD. Furthermore, the assessment and identification of CVD risk among diabetic patients with a high DII using the SII is crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.